Related Tags >> GlaxoSmithKline Entereg FDA safety data

Adolor News

Most Popular Adolor Story

Pfizer, Adolor ink pain drug deal

December 5, 2007 — 6:59am ET

Continuing on its deal-making quest, Pfizer has signed an agreement with Exton, PA-based Adolor for ADL5859 and ADL5747. The two pain drugs Read more...

Adolor Press Releases

Cubist Announces Full Year 2011 Total CUBICIN Net Product Revenues of $735.5 Million, Up 18% Over 2010
Cubist Pharmaceuticals Completes Acquisition of Adolor Corporation
Pathway Therapeutics Announces Appointment of Mark Perry and Dr. Paul Goddard to its Board of Directors
Adolor Corporation Announces Agreement to Acquire Full Ownership of ENTEREG (alvimopan)
Medication Use Evaluation of ENTEREG (alvimopan) Published in the November Edition of The Annals of Pharmacotherapy

Latest Headlines

Cubist Pharma strikes deal to buy Adolor for up to $415M
October 24, 2011
Pfizer opts out of $262M Adolor pain drug pact
December 21, 2010
Adolor cuts 30 jobs as Entereg sales falter
July 16, 2010
Adolor shares sink after placebo effect scuttles PhIIa pain trial
June 18, 2010
Adolor inks $72M deal to in-license Lilly OBD drug
September 22, 2009
Adolor axes 45 workers and shifts clinical focus
June 4, 2009
Progenics, Wyeth drug fails late-stage trial
May 22, 2008
FDA OKs Adolor's Entereg in first approval
May 21, 2008
FDA delays Entereg decision
May 9, 2008
GSK, Adolor face another Entereg delay
February 11, 2008
Entereg wins key FDA advisory committee vote
January 24, 2008
Pfizer, Adolor ink pain drug deal
December 5, 2007
ALSO NOTED: Adolor shares rise on NDA news; Indevus plans Phase III; Exelixis earns milestone; and much more...
November 29, 2007
ALSO NOTED: Vernalis reports "striking" weight loss in trial; Genmab shares surge on Phase III; FDA wants more time on Entereg;
September 13, 2007
Investors cheer FDA's acceptance of Entereg response
August 28, 2007
ALSO NOTED: Judge clears Exubera sales; Obagi prices IPO; Novartis sells med nutrition business; and much more...
December 13, 2006
Adolor hit by FDA's approvable letter for Entereg
November 5, 2006
ALSO NOTED: Adolor to give back pain patch; Dynavax pursues universal flu vaccine; Charles River buys Northwest Kinetics; and m
October 30, 2006
Adolor shares in meltdown on trial data
September 4, 2006
ALSO NOTED: LAB International plans spinoff; Merck backs off Vioxx analysis; and much more...
May 30, 2006

Paid Research Reports

More Research Reports >>